Selected article for: "acute lung injury mechanism and lung injury"

Author: Zhang, Qun; Li, Junyao; Zhong, Haixia; Xu, Yanling
Title: The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway
  • Cord-id: pkn025hx
  • Document date: 2021_9_20
  • ID: pkn025hx
    Snippet: BACKGROUND: Acute lung injury is an important factor that leads to the death of patients with pneumonia. Previous studies have shown that nicotinamide (NAM) plays a role in reducing cell damage, so this study explored the mechanism by which NAM functions in acute lung injury. METHODS: We explored the mechanism by which NAM affects acute lung injury in vivo and in vitro by qRT-PCR, western blotting and ELISA. RESULTS: The results showed that NAM could significantly reduce lung injury and proinfla
    Document: BACKGROUND: Acute lung injury is an important factor that leads to the death of patients with pneumonia. Previous studies have shown that nicotinamide (NAM) plays a role in reducing cell damage, so this study explored the mechanism by which NAM functions in acute lung injury. METHODS: We explored the mechanism by which NAM affects acute lung injury in vivo and in vitro by qRT-PCR, western blotting and ELISA. RESULTS: The results showed that NAM could significantly reduce lung injury and proinflammatory mediator accumulation. Further mechanistic studies showed that NAM could significantly inhibit the MAPK and AKT/NF-κB signaling pathways. CONCLUSION: These results suggested that NAM may reduce the release of proinflammatory mediators by inhibiting the MAPK and AKT/NF-κB signaling pathways and ultimately alleviate lung injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00376-2.

    Search related documents:
    Co phrase search for related documents
    • acute lung inflammation and lps administration: 1, 2, 3, 4, 5, 6
    • acute lung injury and additional file: 1, 2, 3, 4, 5
    • acute lung injury and lps administration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute lung injury and lps group mpo activity: 1
    • acute lung injury and lps induce: 1, 2, 3, 4, 5, 6
    • acute lung injury and lps induce acute lung injury: 1
    • acute lung injury cause and lps administration: 1
    • acute mouse lung injury and lps administration: 1
    • acute mouse lung injury and lps group mpo activity: 1